Stay updated with breaking news from 37416310. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Robert W. Baird lowered shares of Geron (NASDAQ:GERN – Free Report) from an outperform rating to a neutral rating in a report published on Tuesday, MarketBeat Ratings reports. The firm currently has $4.50 price objective on the biopharmaceutical company’s stock. Several other brokerages also recently commented on GERN. Needham & Company LLC restated a buy […]
TD Cowen started coverage on shares of Geron (NASDAQ:GERN – Free Report) in a research report sent to investors on Monday morning, MarketBeat reports. The firm issued a buy rating and a $10.00 price objective on the biopharmaceutical company’s stock. Several other equities research analysts have also commented on the stock. Wedbush reaffirmed an outperform […]
Geron (NASDAQ:GERN – Get Free Report) is set to post its quarterly earnings results before the market opens on Thursday, May 2nd. Analysts expect Geron to post earnings of ($0.10) per share for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link. Geron (NASDAQ:GERN – Get […]
Geron Co. (NASDAQ:GERN – Get Free Report)’s share price reached a new 52-week high during trading on Monday . The company traded as high as $4.05 and last traded at $4.01, with a volume of 6313886 shares traded. The stock had previously closed at $3.79. Analyst Upgrades and Downgrades A number of equities analysts recently […]
Arizona State Retirement System decreased its position in Geron Co. (NASDAQ:GERN – Free Report) by 15.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 109,729 shares of the biopharmaceutical company’s stock after selling 20,647 shares during the quarter. Arizona State Retirement System’s holdings in […]